Researcher Profiles

Return to member profile

Mark N. Stein, MD

Publications since 2011

Tereshchenko, I. V. Zhong, H. Chekmareva, M. A. Kane-Goldsmith, N. Santanam, U. Petrosky, W. Stein, M. N. Ganesan, S. Singer, E. A. Moore, D. Tischfield, J. A. DiPaola, R. S. ERG and CHD1 heterogeneity in prostate cancer: Use of confocal microscopy in assessment of microscopic foci. Prostate, In process, . (PMID: 25175909)

Stein, M. N. Patel, N. Bershadskiy, A. Sokoloff, A. Singer, E. A. Androgen synthesis inhibitors in the treatment of castration-resistant prostate cancer. Asian J Androl, 16:387-400, . (PMID: 24759590, PMCID: PMC4023364)

Tan, A. R. Dowlati, A. Stein, M. N. Jones, S. F. Infante, J. R. Bendell, J. Kane, M. P. Levinson, K. T. Suttle, A. B. Burris Iii, H. A. Phase I study of weekly paclitaxel in combination with pazopanib and lapatinib in advanced solid malignancies. Br J Cancer, 110:2647-2654, . (PMID: 24800949, PMCID: PMC4037836)

Bansal, N. Davis, S. Tereshchenko, I. Budak-Alpdogan, T. Zhong, H. Stein, M. N. Kim, I. Y. Dipaola, R. S. Bertino, J. R. Sabaawy, H. E. Enrichment of human prostate cancer cells with tumor initiating properties in mouse and zebrafish xenografts by differential adhesion. Prostate, 74:187-200, . (PMID: 24154958, PMCID: PMC3939797)

Tan, A. R. Gibbon, D. G. Stein, M. N. Lindquist, D. Edenfield, J. W. Martin, J. C. Gregory, C. Suttle, A. B. Tada, H. Botbyl, J. Stephenson, J. J. Effects of ketoconazole and esomeprazole on the pharmacokinetics of pazopanib in patients with solid tumors. Cancer Chemother Pharmacol, 71:1635-1643, . (PMID: 23636448)

Lee, J. H. Stein, M. Roychowdhury, S. Percutaneous treatment of a sacral metastasis with combined embolization, cryoablation, alcohol ablation and sacroplasty for local tumor and pain control. Interv Neuroradiol, 19:250-253, . (PMID: 23693052, PMCID: PMC3670067)

Shao, Y. H. Kim, S. Moore, D. F. Shih, W. Lin, Y. Stein, M. Kim, I. Y. Lu-Yao, G. L. Cancer-specific Survival After Metastasis Following Primary Radical Prostatectomy Compared with Radiation Therapy in Prostate Cancer Patients: Results of a Population-based, Propensity Score-Matched Analysis. Eur Urol, In process, . (PMID: 23759328)

Raez, L. E. Papadopoulos, K. Ricart, A. D. Chiorean, E. G. Dipaola, R. S. Stein, M. N. Rocha Lima, C. M. Schlesselman, J. J. Tolba, K. Langmuir, V. K. Kroll, S. Jung, D. T. Kurtoglu, M. Rosenblatt, J. Lampidis, T. J. A phase I dose-escalation trial of 2-deoxy-D-glucose alone or combined with docetaxel in patients with advanced solid tumors. Cancer Chemother Pharmacol, 71:523-530, . (PMID: 23228990)

Yue, J. Lu, H. Lan, S. Liu, J. Stein, M. N. Haffty, B. G. Shen, Z. Identification of the DNA repair defects in a case of dubowitz syndrome. PLoS One, 8:e54389, . (PMID: 23372718, PMCID: PMC3556036)

Choueiri, T. K. Vaishampayan, U. Rosenberg, J. E. Logan, T. F. Harzstark, A. L. Bukowski, R. M. Rini, B. I. Srinivas, S. Stein, M. N. Adams, L. M. Ottesen, L. H. Laubscher, K. H. Sherman, L. McDermott, D. F. Haas, N. B. Flaherty, K. T. Ross, R. Eisenberg, P. Meltzer, P. S. Merino, M. J. Bottaro, D. P. Linehan, W. M. Srinivasan, R. Phase II and Biomarker Study of the Dual MET/VEGFR2 Inhibitor Foretinib in Patients With Papillary Renal Cell Carcinoma. J Clin Oncol, In process, . (PMID: 23213094)

Saleem, A. Dvorzhinski, D. Santanam, U. Mathew, R. Bray, K. Stein, M. White, E. Dipaola, R. S. Effect of dual inhibition of apoptosis and autophagy in prostate cancer. Prostate, 72:1374-1381, . (PMID: 22241682)

Lin, H. Gounder, M. K. Bertino, J. R. Kong, A. N. DiPaola, R. S. Stein, M. N. A validated HPLC assay for the determination of R-(-)-gossypol in human plasma and its application in clinical pharmacokinetic studies. J Pharm Biomed Anal, 66:371-375, . (PMID: 22483642, PMCID: PMC3358459)

Holen, K. Dipaola, R. Liu, G. Tan, A. R. Wilding, G. Hsu, K. Agrawal, N. Chen, C. Xue, L. Rosenberg, E. Stein, M. A phase I trial of MK-0731, a Kinesin Spindle Protein (KSP) inhibitor, in patients with solid tumors. Invest New Drugs, 30:1088-1095, . (PMID: 21424701, PMCID: PMC3394096)

Gounder, M. K. Lin, H. Stein, M. Goodin, S. Bertino, J. R. Kong, A. N. DiPaola, R. S. A validated bioanalytical HPLC method for pharmacokinetic evaluation of 2-deoxyglucose in human plasma. Biomed Chromatogr, 26:650-654, . (PMID: 21932382)

Stein, M. Goodin, S. Doyle-Lindrud, S. Silberberg, J. Kane, M. Metzger, D. Eddy, S. Shih, W. DiPaola, R. S. Transdermal estradiol in castrate and chemotherapy resistant prostate cancer. Med Sci Monit, 18:CR260-CR264, . (PMID: 22460098)

Stein, M. N. Goodin, S. Dipaola, R. S. Abiraterone in prostate cancer: a new angle to an old problem. Clin Cancer Res, 18:1848-1854, . (PMID: 22451619)

Saraiya, B. Chugh, R. Karantza, V. Mehnert, J. Moss, R. A. Savkina, N. Stein, M. N. Baker, L. H. Chenevert, T. Poplin, E. A. Phase I study of gemcitabine, docetaxel and imatinib in refractory and relapsed solid tumors. Invest New Drugs, 30:258-265, . (PMID: 20697775)

Bray, K. Mathew, R. Lau, A. Kamphorst, J. J. Fan, J. Chen, J. Chen, H. Y. Ghavami, A. Stein, M. Dipaola, R. S. Zhang, D. Rabinowitz, J. D. White, E. Autophagy Suppresses RIP Kinase-Dependent Necrosis Enabling Survival to mTOR Inhibition. PLoS One, 7:e41831, . (PMID: 22848625, PMCID: PMC3406086)

Bradley, D. A. Daignault, S. Ryan, C. J. Dipaola, R. S. Smith, D. C. Small, E. Gross, M. E. Stein, M. N. Chen, A. Hussain, M. Cilengitide (EMD 121974, NSC 707544) in asymptomatic metastatic castration resistant prostate cancer patients: a randomized phase II trial by the prostate cancer clinical trials consortium. Invest New Drugs, 29:1432-1440, . (PMID: 20336348, PMCID: PMC2917503)

Mehnert, J. M. Tan, A. R. Moss, R. Poplin, E. Stein, M. N. Sovak, M. Levinson, K. Lin, H. Kane, M. Gounder, M. Lin, Y. Shih, W. J. White, E. Rubin, E. H. Karantza, V. Rationally designed treatment for solid tumors with MAPK pathway activation: a phase I study of paclitaxel and bortezomib using an adaptive dose-finding approach. Mol Cancer Ther, 10:1509-1519, . (PMID: 21680752, PMCID: PMC3155243)

Liu, G. Chen, Y. H. Kolesar, J. Huang, W. Dipaola, R. Pins, M. Carducci, M. Stein, M. Bubley, G. J. Wilding, G. Eastern Cooperative Oncology Group Phase II Trial of lapatinib in men with biochemically relapsed, androgen dependent prostate cancer(,). Urol Oncol, In process, . (PMID: 21784672, PMCID: PMC3223557)

Roberts, C. B. Albertsen, P. C. Shao, Y. H. Moore, D. F. Mehta, A. R. Stein, M. N. Lu-Yao, G. L. Patterns and correlates of prostate cancer treatment in older men. Am J Med, 124:235-243, . (PMID: 21396507)